TrialJournal of gastroenterology2019
Withdrawal of thiopurines in Crohn's disease treated with scheduled adalimumab maintenance: a prospective randomised clinical trial (DIAMOND2).
Tadakazu Hisamatsu et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
19 papers cite it
this paperpooled itcites it